6533b870fe1ef96bd12cfafe
RESEARCH PRODUCT
Changes in visual function and retinal structure in the progression of Alzheimer's disease
José RamírezRavi VaziraniRaquel YuberoPedro GilRosa De HozElena Salobrar-garcíaJuan J. SalazarPilar RojasPilar RojasMaria D Pinazo-duranAna I. RamírezInés López-cuencaCarla Amarantesubject
Visual acuitygenetic structuresVisionVisual AcuitySocial SciencesAlzheimer's DiseaseDiagnostic Radiologychemistry.chemical_compound0302 clinical medicineMedicine and Health SciencesContrast (vision)PsychologyTécnicas de la imagenTomographymedia_commonCognitive ImpairmentMultidisciplinaryCognitive NeurologyRadiology and ImagingQRNeurodegenerative Diseasesmedicine.anatomical_structureNeurologyOptic nerveDisease ProgressionMedicineOftalmologíaSensory Perceptionmedicine.symptomAnatomyColor PerceptionTomography Optical CoherenceResearch Articlemedicine.medical_specialtyImaging TechniquesSciencemedia_common.quotation_subjectOcular AnatomyCognitive NeuroscienceResearch and Analysis MethodsRetinaContrast Sensitivity03 medical and health sciencesAlzheimer DiseaseOcular SystemDiagnostic MedicineOphthalmologyMental Health and PsychiatrymedicinePsychophysicsHumansOuter nuclear layerGanglion cell layerVision OcularRetinaColor Visionbusiness.industryBiology and Life SciencesRetinaleye diseasesGeriatríachemistry030221 ophthalmology & optometryEyesCognitive ScienceDementiaChoroidsense organsbusinessHead030217 neurology & neurosurgeryNeurosciencedescription
Background Alzheimer's Disease (AD) can cause degeneration in the retina and optic nerve either directly, as a result of amyloid beta deposits, or secondarily, as a result of the degradation of the visual cortex. These effects raise the possibility that tracking ophthalmologic changes in the retina can be used to assess neurodegeneration in AD. This study aimed to detect retinal changes and associated functional changes in three groups of patients consisting of AD patients with mild disease, AD patients with moderate disease and healthy controls by using non-invasive psychophysical ophthalmological tests and optical coherence tomography (OCT). Methods We included 39 patients with mild AD, 21 patients with moderate AD and 40 age-matched healthy controls. Both patients and controls were ophthalmologically healthy. Visual acuity, contrast sensitivity, colour perception, visual integration, and choroidal thicknesses were measured. In addition, OCT and OCT angiography (OCTA) were applied. Findings Visual acuity, contrast sensitivity, colour perception, and visual integration were significantly lower in AD patients than in healthy controls. Compared to healthy controls, macular thinning in the central region was significant in the mild AD patients, while macular thickening in the central region was found in the moderate AD group. The analysis of macular layers revealed significant thinning of the retinal nerve fibre layer, the ganglion cell layer and the outer plexiform layer in AD patients relative to controls. Conversely, significant thickening was observed in the outer nuclear layer of the patients. However, mild AD was associated with significant thinning of the subfovea and the nasal and inferior sectors of the choroid. Significant superonasal and inferotemporal peripapillary thinning was observed in patients with moderate disease. Conclusions The first changes in the mild AD patients appear in the psychophysical tests and in the central macula with a decrease in the central retinal thickness. When there was a disease progression to moderate AD, psychophysical tests remained stable with respect to the decrease in mild AD, but significant thinning in the peripapillary retina and thickening in the central retina appeared. The presence of AD is best indicated based on contrast sensitivity.
year | journal | country | edition | language |
---|---|---|---|---|
2019-08-15 |